Antibody conjugates

US9315789B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9315789-B2
Application numberUS-201414146389-A
CountryUS
Kind codeB2
Filing dateJan 2, 2014
Priority dateApr 28, 2005
Publication dateApr 19, 2016
Grant dateApr 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Antibody/signal-generating moiety conjugates are disclosed that include an antibody covalently linked to a signal-generating moiety through a heterobifunctional polyalkyleneglycol linker. The disclosed conjugates show exceptional signal-generation in immunohistochemical and in situ hybridization assays on tissue sections and cytology samples. In one embodiment, enzyme-metallographic detection of nucleic acid sequences with hapten-labeled probes can be accomplished using the disclosed conjugates as a primary antibody without amplification.

First claim

Opening claim text (preview).

We claim: 1. An antibody-PEG linker-enzyme signal-generating moiety conjugate, comprising: an antibody; a plurality of enzyme signal-generating moieties; and a plurality of monodisperse, heterobifunctional PEG linkers, wherein each enzyme signal-generating moiety is linked to the antibody through at least one of the plurality of monodisperse, heterobifunctional PEG linker to provide the antibody-PEG linker-enzyme signal-generating moiety conjugate having the formula wherein Ab is the antibody, SM is the enzyme signal-generating moiety, n=4 to 12 and s=3 to 10. 2. The conjugate of claim 1 , wherein SM is an oxido-reductase enzyme. 3. The conjugate of claim 1 , wherein each SM independently is horseradish peroxidase, alkaline phosphatase, acid phosphatase, glucose oxidase, β-galactosidase, β-glucuronidase or β-lactamase. 4. The conjugate of claim 1 , wherein each SM independently is horseradish peroxidase or alkaline phosphatase. 5. The conjugate of claim 1 , wherein SM is alkaline phosphatase. 6. The conjugate of claim 1 , wherein SM is horseradish peroxidase. 7. The conjugate of claim 1 , wherein the antibody comprises an anti-antibody antibody. 8. The conjugate of claim 7 , wherein the anti-antibody antibody is an anti-IgG antibody. 9. The conjugate of claim 1 , wherein the antibody comprises an anti-hapten antibody. 10. The conjugate of claim 1 , wherein s=3 to 6. 11. The conjugate of claim 10 , wherein s=3 to 4. 12. The conjugate of claim 11 , wherein SM is horseradish peroxidase or alkaline phosphatase.

Assignees

Inventors

Classifications

  • with enzyme label {or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates} · CPC title

  • against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title

  • C12N9/16Primary

    acting on ester bonds (3.1) · CPC title

  • acting on hydrogen peroxide as acceptor (1.11) · CPC title

  • against immunoglobulins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9315789B2 cover?
Antibody/signal-generating moiety conjugates are disclosed that include an antibody covalently linked to a signal-generating moiety through a heterobifunctional polyalkyleneglycol linker. The disclosed conjugates show exceptional signal-generation in immunohistochemical and in situ hybridization assays on tissue sections and cytology samples. In one embodiment, enzyme-metallographic detection o…
Who is the assignee on this patent?
Ventana Med Syst Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).